Synklino Strengthens Management Team with Key Appointments

Synklino ApS, an emerging biotech company developing first-in-class breakthrough treatment to eliminate cytomegalovirus (CMV) infections in the transplant setting, today announces the appointment of Tolga Hassan as Chief Finance Officer (CFO) and Dr. Josefin-Beate (Josi) Holz as Chief Medical Officer (CMO). This announcement follows the recent closing of a financing round led by Eir Ventures and Vaekstfonden.

Read more….

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...